Profile
K.
Chris Min worked as a Senior Medical Director-Neurology at Bluerock Therapeutics, Inc. and as VP, Head-Medical & Clinical Development at Enterin, Inc. In 2023, he served as the Chief Medical Officer at Longeveron, Inc. Dr. Min completed his undergraduate degree at Harvard University and earned his doctorate degrees from The Rockefeller University and Weill Cornell Medical College.
Former positions of K. Min
| Companies | Position | End |
|---|---|---|
| LONGEVERON INC. | Chief Executive Officer | 28/02/2023 |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 31/03/2021 |
| Bluerock Therapeutics, Inc. | Corporate Officer/Principal | - |
Training of K. Min
| Harvard University | Undergraduate Degree |
| The Rockefeller University | Doctorate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Private companies | 2 |
|---|---|
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
| Bluerock Therapeutics, Inc. |
- Stock Market
- Insiders
- K. Min
